SCHEDULE: VSEE Health: Investor Group Discloses 9.9% Stake

A group of investors, including Dominion Capital and Ascent Partners, has disclosed a 9.9% beneficial ownership stake in VSEE Health, Inc. through a Schedule 13G filing.

Summary

• A group of nine reporting persons, including Dominion Capital LLC, Ascent Partners Fund LLC, and individuals Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner, has filed a Schedule 13G for VSEE Health, Inc.
• The group collectively beneficially owns 1,816,389 shares of VSEE Health, Inc. common stock.
• This represents 9.9% of the company's outstanding common stock.
• The ownership calculation is based on 16,422,690 shares outstanding as of August 27, 2025, plus 600,000 shares converted by Dominion Capital on September 3, 2025, totaling 17,022,690 shares.
• The beneficial ownership also accounts for shares issuable upon conversion of Convertible Notes and exercise of Warrants, all subject to a 9.99% beneficial ownership limitation, referred to as the 'Blocker Amount'.
• Dominion Capital and Ascent Partners Fund directly hold Convertible Notes and Warrants, which are convertible/exercisable into a significant number of shares, subject to the Blocker.
• The reporting persons have shared voting and dispositive power over all 1,816,389 beneficially owned shares.
• The acquisition of securities was not for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: The filing indicates a significant, albeit passive, investment by a group of entities and individuals, which can be seen as a vote of confidence. The 'Blocker Amount' limits immediate influence, suggesting a long-term, non-activist stance for now. No explicit negative information is present.

Positives

• A significant investor group has taken a substantial stake, potentially indicating confidence in VSEE Health, Inc.
• The group's beneficial ownership is capped at 9.99% due to 'Blocker Amount' provisions, which can prevent immediate hostile takeover attempts or rapid accumulation beyond a certain threshold without further disclosure.

Negatives

• The filing itself does not present explicit negative financial or operational information.
• The existence of a 'Blocker Amount' suggests a mechanism to limit the influence of large shareholders, which could be seen as a constraint on potential activist investors.

Risks

• The 'Blocker Amount' provisions in Convertible Notes and Warrants limit the immediate conversion/exercise to prevent beneficial ownership exceeding 9.99%, which could restrict the reporting persons' ability to fully realize their potential ownership or influence.
• The complex interrelationships and management structure among the reporting entities (Dominion Capital, Ascent Partners, Masada Group, and individuals) could lead to complex decision-making processes.

Future Outlook

The filing indicates that Dominion Capital and Ascent Partners Fund LLC have initiated a process to increase their beneficial ownership limitation (Blocker provision) in their Convertible Notes and Warrants to 9.99% combined, which will become effective 61 days after September 30, 2025.

Management Comments

• The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This Schedule 13G filing is a standard disclosure of a significant passive investment stake in VSEE Health, Inc. It does not provide specific industry-related insights or trends, but rather reflects an investment decision by a group of entities and individuals in the healthcare technology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The disclosure of a significant 9.9% stake by a group of investors could be viewed positively, signaling external confidence. The 'Blocker Amount' limits the immediate dilution impact from full conversion/exercise of notes and warrants.
• Management: The certification that the stake is not for control purposes (other than Rule 14a-11 nominations) suggests a non-confrontational approach from this investor group, at least initially.

Next Steps

• The increased Blocker provision in the Convertible Notes and Warrants held by Dominion Capital and Ascent Partners Fund LLC will become effective 61 days after September 30, 2025.

Key Dates

Recommendation

The filing indicates a significant, passive investment by a group of entities and individuals in VSEE Health, Inc., reaching a 9.9% beneficial ownership stake. While this signals confidence from a notable investor group, the 'Blocker Amount' provisions limit their immediate ability to convert all convertible notes and warrants, suggesting a non-activist or long-term passive investment strategy for now. There is no explicit information in the filing to suggest a strong buy or sell, as it is primarily a disclosure of ownership rather than a performance update or strategic shift. The investment is substantial enough to warrant attention but lacks catalysts for immediate strong action.

Keywords

VSEE Health Inc., Schedule 13G, Beneficial Ownership, Dominion Capital LLC, Ascent Partners Fund LLC, Mikhail Gurevich, Gennadiy Gurevich, Alon Brenner, Convertible Notes, Warrants, Equity Stake, Investment Group, Shareholder Disclosure